Shengyan Xiang

1.4k total citations
25 papers, 919 citations indexed

About

Shengyan Xiang is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Shengyan Xiang has authored 25 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 2 papers in Neurology. Recurrent topics in Shengyan Xiang's work include Epigenetics and DNA Methylation (9 papers), Histone Deacetylase Inhibitors Research (7 papers) and Peptidase Inhibition and Analysis (5 papers). Shengyan Xiang is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Histone Deacetylase Inhibitors Research (7 papers) and Peptidase Inhibition and Analysis (5 papers). Shengyan Xiang collaborates with scholars based in United States, China and Switzerland. Shengyan Xiang's co-authors include Wenlong Bai, Gerold Bepler, Xiaohong Zhang, Saı̈d M. Sebti, Dajun Deng, Baozhen Zhang, Hua Yang, Mu Zhang, Aslamuzzaman Kazi and José G. Treviño and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Shengyan Xiang

24 papers receiving 911 citations

Peers

Countries citing papers authored by Shengyan Xiang

Since Specialization

Citations

This map shows the geographic impact of Shengyan Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyan Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyan Xiang more than expected).

Fields of papers citing papers by Shengyan Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyan Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyan Xiang. The network helps show where Shengyan Xiang may publish in the future.

Co-authorship network of co-authors of Shengyan Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shengyan Xiang. A scholar is included among the top collaborators of Shengyan Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengyan Xiang. Shengyan Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of EST-SSR characteristics of prickly ash transcriptome and development of molecular markers 2025 ·Scientific Reports ·Jiamin Liu, (unknown), Shengyan Xiang, Jin Du, Rui Zhang, (unknown), (unknown), (unknown), Zhixin Ma, (unknown), Zexiong Chen	0
2	Identification of ATP-Competitive Human CMG Helicase Inhibitors for Cancer Intervention that Disrupt CMG-Replisome Function 2024 ·Molecular Cancer Therapeutics ·Shengyan Xiang, (unknown), (unknown), (unknown), Renan B. Ferreira, Harshani R. Lawrence, Nicholas J. Lawrence, Damon R. Reed, Mark G. Alexandrow	1
3	Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy 2023 ·Scientific Reports ·(unknown), Brooke L. Fridley, Ling Cen, Jamie K. Teer, Sean Yoder, Fredrik Pettersson, Liping Xu, Chia‐Ho Cheng, Yonghong Zhang, Mark G. Alexandrow, Shengyan Xiang, Mark Robertson‐Tessi, Joel S. Brown, (unknown), Andrew S. Brohl, Damon R. Reed	2
4	759P Preconditioning with irradiation enhances efficacy of B7-H3-CAR-T in treating solid tumor models 2022 ·Annals of Oncology ·(unknown), (unknown), Yinyin Li, Shengyan Xiang, (unknown), (unknown), (unknown), (unknown), (unknown)	2
5	Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer 2021 ·Clinical Cancer Research ·Aslamuzzaman Kazi, Liwei Chen, Shengyan Xiang, (unknown), Hua Yang, Francisca Beato, Bin Fang, Terence M. Williams, Kazim Husain, Patrick W. Underwood, Jason B. Fleming, Mokenge P. Malafa, Eric A. Welsh, John M. Koomen, José G. Treviño, Saı̈d M. Sebti	25
6	The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53 2020 ·Cell Death and Disease ·Hu Chen, Mu Zhang, (unknown), (unknown), Lisa Polin, Wei Chen, Hyejeong Jang, Joshua Heyza, (unknown), Joseph A. Caruso, Shengyan Xiang, Steve M. Patrick, Paul M. Stemmer, Zhenkun Lou, Wenlong Bai, Chuangui Wang, Gerold Bepler, (unknown)	48
7	The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells 2020 ·Journal of Biological Chemistry ·Hua Yang, Shengyan Xiang, (unknown), Saı̈d M. Sebti	23
8	Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors 2019 ·Clinical Cancer Research ·Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, Liwei Chen, Perry Kennedy, Muhammad Ayaz, Steven Fletcher, Christopher T. Cummings, Harshani R. Lawrence, Francisca Beato, Ya’an Kang, Michael P. Kim, Andrea E. Delitto, Patrick W. Underwood, Jason B. Fleming, José G. Treviño, Andrew D. Hamilton, Saı̈d M. Sebti	53
9	GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors 2018 ·Nature Communications ·Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, Daniel Delitto, José G. Treviño, Rays H. Y. Jiang, Muhammad Ayaz, Harshani R. Lawrence, Perry Kennedy, Saı̈d M. Sebti	99
10	Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells 2016 ·Clinical Cancer Research ·Xiaojia Niu, Jianyun Zhao, Jun Ma, Chengzhi Xie, Holly Edwards, Guan Wang, J. Timothy Caldwell, Shengyan Xiang, Xiaohong Zhang, Roland Chu, Zhihong J. Wang, Hai Lin, Jeffrey W. Taub, Yubin Ge	181
11	Murine Pancreatic Adenocarcinoma Reduces Ikaros Expression and Disrupts T Cell Homeostasis 2015 ·PLoS ONE ·(unknown), Shengyan Xiang, Xiaohong Zhang, Danielle L. Gilvary, Julie Y. Djeu, Kazim Husain, Mokenge P. Malafa, Nasreen A. Vohra, Shari Pilon‐Thomas, Tomar Ghansah	5
12	Histone Deacetylase 10 Regulates DNA Mismatch Repair and May Involve the Deacetylation of MutS Homolog 2 2015 ·Journal of Biological Chemistry ·Rangasudhagar Radhakrishnan, Yixuan Li, Shengyan Xiang, Fenghua Yuan, Zhigang Yuan, (unknown), Jia Fang, Domenico Coppola, David Shibata, William S. Lane, Yanbin Zhang, Xiaohong Zhang, Edward Seto	45
13	HDAC6-Dependent Functions in Tumor Cells: Crossroad with the MAPK Pathways 2014 ·Critical Reviews™ in Oncogenesis ·(unknown), (unknown), Shengyan Xiang, Kendra A. Williams, Wenlong Bai, Xiaohong Zhang	8
14	C-terminal in Sp1-like artificial zinc-finger proteins plays crucial roles in determining their DNA binding affinity 2013 ·BMC Biotechnology ·Baozhen Zhang, Shengyan Xiang, Yanru Yin, Liankun Gu, Dajun Deng	3
15	Extracellular Signal-regulated Kinase (ERK) Phosphorylates Histone Deacetylase 6 (HDAC6) at Serine 1035 to Stimulate Cell Migration 2013 ·Journal of Biological Chemistry ·Kendra A. Williams, Mu Zhang, Shengyan Xiang, Hu Chen, (unknown), Shengping Zhang, Meagan B. Ryan, Adrienne D. Cox, Channing J. Der, Bin Fang, John M. Koomen, Eric B. Haura, Gerold Bepler, Santo V. Nicosia, Patrick Matthias, Chuangui Wang, Wenlong Bai, Xiaohong Zhang	90
16	The p16- Specific Reactivation and Inhibition of Cell Migration Through Demethylation of CpG Islands by Engineered Transcription Factors 2012 ·Human Gene Therapy ·Baozhen Zhang, Shengyan Xiang, (unknown), Yanru Yin, Liankun Gu, Dajun Deng	19
17	Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells 2012 ·PLoS ONE ·Lei Wang, Shengyan Xiang, Kendra A. Williams, Huiqin Dong, Wenlong Bai, Santo V. Nicosia, Saadi Khochbin, Gerold Bepler, Xiaohong Zhang	64
18	Inhibition of androgen receptor activity by histone deacetylase 4 through receptor SUMOylation 2011 ·Oncogene ·Yonghua Yang, (unknown), Pei Li, Qiuping Ma, Shengyan Xiang, S V Nicosia, Edward Seto, X Zhang, Wenlong Bai	61
19	Methylation status of individual CpG sites within Alu elements in the human genome and Alu hypomethylation in gastric carcinomas 2010 ·BMC Cancer ·Shengyan Xiang, Zhaojun Liu, Baozhen Zhang, Jing Zhou, (unknown), Jiafu Ji, Dajun Deng	33
20	Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas 2006 ·Laboratory Investigation ·Daya Luo, Baozhen Zhang, (unknown), Shengyan Xiang, (unknown), Jiafu Ji, Dajun Deng	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact